Place of Comprehensive Geriatric Assessment in Patients ≥ 75 Years Care, With Breast Cancer, After Screening With FOG (Oncology Geriatric Filter)
NCT ID: NCT03059875
Last Updated: 2021-09-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
79 participants
INTERVENTIONAL
2014-01-30
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients in the intermediate group (FOG 1-3) are randomized to determine time of CGA, before or after surgery.
The aims of this study are to assess the outcomes regarding the time of CGA, in elderly female patients with breast cancer management, and to define the optimal place of CGA in care pathway.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tool for the Detection of Oncogeriatric Fragility in Patients Aged ≥75 Years Undergoing Oncological Treatment.(D-FOG)
NCT03261128
Understanding Needs of Older Patients Prior to Starting Cancer Treatment
NCT07225920
Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE)
NCT02704832
Impact of Oncogeriatric Consultation on Quality of Life of Patients Aged 75 and More With Cancer
NCT05163015
Nursing Follow up in Geriatric Oncology : Tracking Time of Caregiver Exhaustion Risk
NCT02551965
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Strategy A
Comprehensive Geriatric Assessment before the surgery of breast
Medical consultation for a Standardized Geriatric Evaluation
Strategy B
Comprehensive Geriatric Assessment after the surgery of breast
Medical consultation for a Standardized Geriatric Evaluation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Medical consultation for a Standardized Geriatric Evaluation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Onco-geriatric filter (FOG) \>= 1 ou \< 4
Exclusion Criteria
* Contraindication of surgery
* Breast cancer with metastasis
* Onco-geriatric filter (FOG) = 0 or 4
75 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Poitiers University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Center
Angoulême, , France
Hospital center
Bressuire, , France
Hospital Center
La Rochelle, , France
Hospital center
Niort, , France
University Hospital Center
Poitiers, , France
Hospital center
Saintes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GYNECO ONCOGER
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.